Amicus Briefs Filed in Amgen v. Sandoz

Amgen v. Sandoz (filgrastim)  •  Approved Biosimilar Products  •  Biosimilar News  •  BPCIA and Related U.S. Statutes  •  Janssen v. Celltrion (infliximab)  •  U.S. Biosimilar Litigation News  •  U.S. Federal Circuit Decisions

Hospira, Inc., Celltrion Healthcare Co., Ltd., and Celltrion Inc. (jointly) and the Biosimilars Council filed amicus briefs today in support of Sandoz’s petition for rehearing en banc in Amgen v. Sandoz.  The briefs are now publicly available and are attached here and here.

UPDATE: Mylan Inc. has also filed an amicus brief in support of Sandoz’s petition for rehearing en banc.  The brief is available here.

Download PDF

Comments are closed.